1-11 of 11
Mark E. Lustberg
Close
Sort by
Journal Articles

The Epstein-Barr Virus Lytic Protein BZLF1 As a Candidate Target Antigen for Vaccine Development

Alex S. Hartlage, Tom Liu, PhD, John T. Patton, Sabrina L Garman, Xiaoli Zhang, PhD MS, Habibe Kurt, MD, Gerard Lozanski, MD, Mark E Lustberg, MD PhD, Michael A. Caligiuri, MD, Robert A. Baiocchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4144.
https://doi.org/10.1182/blood.V124.21.4144.4144
Published: 2014
Journal Articles

Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder

James Dugan, MD MS, Bradley M. Haverkos, MD MPH, Ludmila Katherine Martin, MD, Marisa F. Martin, Mark E Lustberg, MD PhD, John T. Patton, PhD, Gerard Nuovo, MD, Fengting Yan, MD, PhD, Robert Cavaliere, MD, Shannon C. Kenney, MD, Joyce Fingeroth, MD, Gerard Lozanski, MD, Juan Carlos Ramos, MD, Pierluigi Porcu, MD, Michael A. Caligiuri, MD, Robert A. Baiocchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1750.
https://doi.org/10.1182/blood.V124.21.1750.1750
Published: 2014
Journal Articles

Silvestrol Modulates Indirect Anti-Tumor Activity and Potentiates Immune Response To Epstein-Barr Virus-Driven Lymphoproliferative Disease

John T. Patton, Alex S. Hartlage, Li Pan, PhD, Mark E Lustberg, MD, PhD, Callie M. Drohan, Marisa F. Martin, A. Douglas Kinghorn, Ph.D., D.Sc, Michael A. Caligiuri, MD, Michael R. Grever, MD, David M. Lucas, PhD, Robert A. Baiocchi, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 4422.
https://doi.org/10.1182/blood.V122.21.4422.4422
Published: 2013
Journal Articles

Protein Arginine Methyltransferase 5 (PRMT5) Over-Expression Is Essential for Epstein-Barr Virus-Driven B-Cell Transformation.

Lapo Alinari, MD., Ph.D., Fengting Yan, M.D., Ph.D., Porsha Smith, John T. Patton, Carl Quinion, Bo Yu, Ph.D, Christian Tyler Earl, Mark E Lustberg, MD, PhD, Lynda Villagomez, Erin K Hertlein, PhD, John C. Byrd, MD, Leona Ayers, MD, Tasneem Motiwala, PhD, Sarmila Majumder, PhD, Chenglong Li, Ph.D., Said Sif, Ph.D., Samson T. Jacob, PhD, Robert A. Baiocchi, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 2378.
https://doi.org/10.1182/blood.V120.21.2378.2378
Published: 2012
Journal Articles

Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Anissa Bingman, M.S., Gerard Lozanski, M.D., Robert A. Baiocchi, M.D., Ph.D., William Falk, B.S., Don M. Benson, Jr., MD, PhD, Yvonne A Efebera, M.D., Kristina Humphries, M.S., Megan Sell, RN, MS, Carli N Greenfield, RN, MSN, ACNP, Mark E Lustberg, MD, PhD, John L. Vaughn, BS, Christian Tyler Earl, Susan Geyer, PhD, Steven M. Devine, MD
Journal: Blood
Blood (2012) 120 (21): 4460.
https://doi.org/10.1182/blood.V120.21.4460.4460
Published: 2012
Journal Articles

Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Robert A. Baiocchi, M.D., Ph.D., Gerard Lozanski, M.D., Kristina Humphries, M.S., Kristie A. Blum, MD, Pierluigi Porcu, MD, Sam Penza, MD, Carli N Greenfield, RN, MSN, ACNP, Megan Sell, RN, MS, Christian Tyler Earl, Joseph Zitesman, B.S., Carl Quinion, Mark E Lustberg, MD, PhD, Leslie A Andritsos, MD, Steven M. Devine, MD
Journal: Blood
Blood (2012) 120 (21): 2004.
https://doi.org/10.1182/blood.V120.21.2004.2004
Published: 2012
Journal Articles

Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma,

Beth Christian, MD, Lapo Alinari, MD., Ph.D., Jeffrey A. Jones, MD, MPH, Don M Benson, Jr., MD, PhD, Joseph M. Flynn, DO, MPH, Pierluigi Porcu, MD, Mark E Lustberg, MD, PhD, Mitchell Phelps, Ph.D., Ming Poi, PharmD, PhD, Diana Chung, BS, Carl Quinion, John C. Byrd, MD, William Wegener, MD, PhD, David M Goldenberg, Robert A. Baiocchi, M.D., Ph.D., Kristie A. Blum, MD
Journal: Blood
Blood (2011) 118 (21): 3707.
https://doi.org/10.1182/blood.V118.21.3707.3707
Published: 2011
Journal Articles

Silvestrol Modulates Direct Anti-Tumor Activity Against Epstein-Barr Virus (EBV)-Associated Lymphomas While Sparing Innate and Antigen Specific Adaptive Immunity

John T. Patton, Mark E Lustberg, MD, PhD, Sabrina L Garman, A Douglas Kinghorn, Ph.D., D.Sc, Li Pan, PhD, David M. Lucas, PhD, Michael R. Grever, M.D., Robert A. Baiocchi, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 104.
https://doi.org/10.1182/blood.V118.21.104.104
Published: 2011
Journal Articles

Risk Factors for Post-Transplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

Mark E Lustberg, MD, PhD, Ronald Pelletier, MD, Pierluigi Porcu, MD, Stanley Martin, MD, Robert A. Baiocchi, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 4465.
https://doi.org/10.1182/blood.V118.21.4465.4465
Published: 2011
Journal Articles

Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series

Ludmila Katherine Martin, MD, Mark E Lustberg, MD, PhD, Fengting Yan, M.D., Ph.D., John T. Patton, Pierluigi Porcu, MD, Gerard Nuovo, M.D., Robert Cavaliere, MD, Robert A. Baiocchi, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 3067.
https://doi.org/10.1182/blood.V118.21.3067.3067
Published: 2011
Journal Articles

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma

Lapo Alinari, Bo Yu, Beth A. Christian, Fengting Yan, Jungook Shin, Rosa Lapalombella, Erin Hertlein, Mark E. Lustberg, Carl Quinion, Xiaoli Zhang, Gerard Lozanski, Natarajan Muthusamy, Mette Prætorius-Ibba, Owen A. O'Connor, David M. Goldenberg, John C. Byrd, Kristie A. Blum, Robert A. Baiocchi
Journal: Blood
Blood (2011) 117 (17): 4530–4541.
https://doi.org/10.1182/blood-2010-08-303354
Published: 2011
Includes: Supplemental data